DK1981515T3 - MAPC behandling af hjerneskader og -sygdomme - Google Patents

MAPC behandling af hjerneskader og -sygdomme

Info

Publication number
DK1981515T3
DK1981515T3 DK07762457.5T DK07762457T DK1981515T3 DK 1981515 T3 DK1981515 T3 DK 1981515T3 DK 07762457 T DK07762457 T DK 07762457T DK 1981515 T3 DK1981515 T3 DK 1981515T3
Authority
DK
Denmark
Prior art keywords
diseases
brain injuries
mapc
treatment
mapc treatment
Prior art date
Application number
DK07762457.5T
Other languages
Danish (da)
English (en)
Inventor
Robert W Mays
Robert J Deans
David C Hess
James E Carroll
Cesar V Borlongan
Original Assignee
Athersys Inc
Med College Georgia Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Athersys Inc, Med College Georgia Res Inst filed Critical Athersys Inc
Application granted granted Critical
Publication of DK1981515T3 publication Critical patent/DK1981515T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK07762457.5T 2006-01-23 2007-01-23 MAPC behandling af hjerneskader og -sygdomme DK1981515T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76095106P 2006-01-23 2006-01-23
PCT/US2007/001746 WO2007087292A2 (en) 2006-01-23 2007-01-23 Mapc treatment of brain injuries and diseases

Publications (1)

Publication Number Publication Date
DK1981515T3 true DK1981515T3 (da) 2013-07-22

Family

ID=40280746

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07762457.5T DK1981515T3 (da) 2006-01-23 2007-01-23 MAPC behandling af hjerneskader og -sygdomme

Country Status (9)

Country Link
EP (1) EP1981515B1 (https=)
JP (1) JP5432527B2 (https=)
AU (1) AU2007208367B2 (https=)
CA (1) CA2642826C (https=)
DK (1) DK1981515T3 (https=)
ES (1) ES2420957T3 (https=)
NZ (1) NZ570614A (https=)
PL (1) PL1981515T3 (https=)
WO (1) WO2007087292A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2471907T3 (pl) 2005-12-29 2019-07-31 Celularity, Inc. Populacje komórek macierzystych łożyska
CA2734237C (en) * 2008-08-20 2019-07-02 Anthrogenesis Corporation Treatment of stroke using isolated placental cells
KR20200011604A (ko) 2008-08-20 2020-02-03 안트로제네시스 코포레이션 개선된 세포 조성물 및 그의 제조 방법
SG10201807935SA (en) * 2008-09-04 2018-10-30 Abt Holding Co Use of stem cells to prevent neuronal dieback
SG178064A1 (en) * 2009-07-21 2012-03-29 Abt Holding Co Use of stem cells to reduce leukocyte extravasation
WO2011106521A1 (en) * 2010-02-25 2011-09-01 Abt Holding Company Modulation of macrophage activation
WO2011106476A1 (en) * 2010-02-25 2011-09-01 Abt Holding Company Modulation of microglia activation
WO2012092485A1 (en) 2010-12-31 2012-07-05 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory rna molecules
ES2707579T3 (es) 2011-06-01 2019-04-04 Celularity Inc Tratamiento del dolor usando citoblastos placentarios
KR20160098244A (ko) * 2013-11-15 2016-08-18 안트로제네시스 코포레이션 사람 태반 관류액 세포를 포함하는 조성물, 상기 세포의 부분모집단 및 이의 용도
CN105331583B (zh) * 2015-12-08 2019-01-29 广州医科大学附属第三医院 一种促进人诱导多能干细胞向神经元诱导分化的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4353888A (en) 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
US4749620A (en) 1984-02-15 1988-06-07 Massachusetts Institute Of Technology Encapsulated active material system
US4744933A (en) 1984-02-15 1988-05-17 Massachusetts Institute Of Technology Process for encapsulation and encapsulated active material system
JPH0628570B2 (ja) 1986-02-13 1994-04-20 雪印乳業株式会社 カプセル体の製造方法及び装置
EP0301777A1 (en) 1987-07-28 1989-02-01 Queen's University At Kingston Multiple membrane microencapsulation
US5089272A (en) 1989-03-29 1992-02-18 Snow Brand Milk Products Co., Ltd. Process for producing capsules having a permeability-controllable membrane
US5084350A (en) 1990-02-16 1992-01-28 The Royal Institution For The Advance Of Learning (Mcgill University) Method for encapsulating biologically active material including cells
US5578442A (en) 1992-03-23 1996-11-26 Vivorx, Inc. Graft copolymers of polycationic species and water-soluble polymers, and use therefor
ATE218893T1 (de) 1993-08-12 2002-06-15 Neurotech Sa Biokompatible immunoisolatorische kapseln, die genetisch veränderte zellen enthalten
US6306434B1 (en) 1997-02-12 2001-10-23 Chong Kun Dang Corp. Pharmaceutical composition comprising cyclosporin solid-state microemulsion
US7015037B1 (en) 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
US7838289B2 (en) 2001-02-14 2010-11-23 Abt Holding Company Assay utilizing multipotent adult stem cells
US9969980B2 (en) * 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
EP1471970A4 (en) * 2002-01-14 2006-08-02 Univ Illinois NOVEL MULTIPOTENT STEM CELLS OF MAMMALIAN ORIGIN, METHODS OF PREPARATION AND METHODS OF ADMINISTRATION OF SAID CELLS
WO2004099395A2 (en) * 2003-05-08 2004-11-18 Cellartis Ab A method for the generation of neural progenitor cells

Also Published As

Publication number Publication date
AU2007208367B2 (en) 2013-05-16
WO2007087292A3 (en) 2007-11-22
JP5432527B2 (ja) 2014-03-05
EP1981515A2 (en) 2008-10-22
AU2007208367A1 (en) 2007-08-02
JP2009523846A (ja) 2009-06-25
CA2642826C (en) 2019-01-08
ES2420957T3 (es) 2013-08-28
PL1981515T3 (pl) 2014-02-28
NZ570614A (en) 2012-07-27
EP1981515B1 (en) 2013-04-24
WO2007087292A2 (en) 2007-08-02
CA2642826A1 (en) 2007-08-02

Similar Documents

Publication Publication Date Title
DK1981515T3 (da) MAPC behandling af hjerneskader og -sygdomme
DK2222272T3 (da) Behandling af luftvejssygdom
EP2118300A4 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
BRPI0812361A2 (pt) Derivados de pirazol heteroaril-substituídos úteis parao tratamento de distúrbios e doenças hiperproliferativos associados à angiogênese
DK2056807T3 (da) Behandling af inflammatoriske sygdomme
DK2056842T3 (da) Modificeret galactosylceramid til behandling af cancerøse sygdomme
ATE531720T1 (de) Aza-benzofuranylverbindungen und anwendungsverfahren dafür
BRPI0821779A2 (pt) tratamento terapêutico de câncer
BRPI0811265A2 (pt) Tratamento de sinucleinopatias
EP1830876A4 (en) TREATMENT OF SKIN METALS
BRPI0815551A2 (pt) Tratamento através de hucbc de doença beta-amiloide
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
DK2004204T3 (da) Behandling af neurodegenerative sygdomme med selenat
BRPI1014864A2 (pt) "implante de processos espinhosos e métodos associados"
EP2278999C0 (en) EAR PREPARATIONS FOR THE TREATMENT OF EAR DISEASES AND CONDITIONS
DK2245199T3 (da) Anvendelse af mikrovesikler i diagnosticering, prognosticering og behandling af medicinske sygdomme og tilstande
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
DE602007002740D1 (de) Trokar und Behandlungssystem
DK2538986T3 (da) Intraartikulært supplement til anvendelse til behandling af ledsygdomme og -skader
BRPI0820477A2 (pt) Compostos de benzodiazepinona úteis no tratamento de afecções da pele
DK1890684T3 (da) Behandling af søvn/vågenhedsforstyrrelser
DE602008001981D1 (de) Stellung und therapeutische verwendung
DK2236149T3 (da) Medicinsk sammensætning til behandling af respiratoriske infektions-sygdomme
BRPI1013004A2 (pt) "elementos de filtro e conjunto de filtro"
DK2056858T3 (da) Behandling af lungesygdomstilstande